Abstract
Costimulatory signals are important for development of effector and regulatory T cells. In this case, CD28 signaling is usually considered inert in the absence of signaling through the TCR. By contrast, mitogenic rat CD28 mAb reportedly expand regulatory T cells without TCR stimulation. We found that a commercially available human CD28 mAb (ANC28) stimulated PBMC without TCR co-ligation or cross-linking; ANC28 selectively expanded CD4(+)CD25(+)FOXP3(-) (Teff) and CD4(+)CD25(+)FOXP3(+) (Treg) cells. ANC28 stimulated the CD45RO(+) CD4(+) (memory) population, whereas CD45RA(+)CD4(+) (naive) cells did not respond. ANC28 also induced inflammatory cytokines. Treg induced by ANC28 retain the Treg phenotype longer than costimulated Treg. Treg induced by ANC28 suppressed CD25(-) T cells through a contact-dependent mechanism. Purity influenced the response of CD4(+)CD25(+ )cells because bead-purified CD4(+)CD25(+ )cells (85-90% pure) responded strongly to ANC28, whereas 98% pure FACS-sorted CD4(+)CD25(bright) (Treg) did not respond. Purified CD4(+)CD25(int) cells responded similarly to the bead-purified CD4(+)CD25(+) cells. Thus, pre-activated CD4(+) T cells (CD25(int)) respond to ANC28 rather than Treg (CD25(bright)). The ability of ANC28 to expand both effectors producing inflammatory cytokines as well as suppressive regulatory T cells might be useful for ex vivo expansion of therapeutic T cells.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Adult
-
Androstadienes / pharmacology
-
Antibodies, Monoclonal / immunology
-
Antibodies, Monoclonal / pharmacology*
-
CD28 Antigens / immunology*
-
CD4-Positive T-Lymphocytes / drug effects
-
CD4-Positive T-Lymphocytes / immunology*
-
CD4-Positive T-Lymphocytes / metabolism
-
Cell Differentiation / drug effects
-
Cell Differentiation / immunology
-
Cell Proliferation / drug effects
-
Coculture Techniques
-
Cytokines / metabolism*
-
Enzyme Inhibitors / pharmacology
-
Forkhead Transcription Factors / analysis
-
Humans
-
Immunoglobulin Fab Fragments / immunology
-
Immunoglobulin Fab Fragments / pharmacology
-
Interleukin-2 Receptor alpha Subunit / analysis
-
Leukocyte Common Antigens / analysis
-
Leukocytes, Mononuclear / drug effects
-
Leukocytes, Mononuclear / immunology
-
Leukocytes, Mononuclear / metabolism
-
Lymphocyte Activation / drug effects
-
Phosphodiesterase Inhibitors / pharmacology
-
Phosphoinositide-3 Kinase Inhibitors
-
Signal Transduction / drug effects
-
T-Lymphocyte Subsets / drug effects
-
T-Lymphocyte Subsets / immunology
-
T-Lymphocyte Subsets / metabolism
-
T-Lymphocytes / drug effects
-
T-Lymphocytes / immunology
-
T-Lymphocytes / metabolism
-
T-Lymphocytes, Regulatory / cytology
-
T-Lymphocytes, Regulatory / drug effects
-
T-Lymphocytes, Regulatory / immunology*
-
Wortmannin
Substances
-
Androstadienes
-
Antibodies, Monoclonal
-
CD28 Antigens
-
Cytokines
-
Enzyme Inhibitors
-
FOXP3 protein, human
-
Forkhead Transcription Factors
-
Immunoglobulin Fab Fragments
-
Interleukin-2 Receptor alpha Subunit
-
Phosphodiesterase Inhibitors
-
Phosphoinositide-3 Kinase Inhibitors
-
Leukocyte Common Antigens
-
Wortmannin